Table 4 Meta-analysis for the efficacy of colchicine on need for ICU admission in patients with COVID-19
From: The role of colchicine in the management of COVID-19: a Meta-analysis
Study | Type of study | Relative Risk | 95% CI | P-value |
|---|---|---|---|---|
Deftereos et al. 2020 | RCT | 0.12 | 0.01–1.05 | 0.025696 |
Lopes et al. 2021 | RCT | 0.47 | 0.08–2.75 | 0.393769 |
Fixed Effect Model | 0.29 | 0.07–1.17 | – | |